Autopsy report · NCT05492500
A Study of Ponsegromab in People With Heart Failure
Cause of deathFunding or business
“Following a prespecified interim analysis, and in consultation with the independent Data Monitoring Committee, the Sponsor terminated the study”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 5 months before it stopped.
- 455 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Heart Failure
- Interventions
- Main cohort (Cohort A): Ponsegromab low dose; Main cohort (Cohort A): Ponsegromab medium dose; Main cohort (Cohort A): ponsegromab high dose; Main cohort (Cohort A): Matched placebo; Open-label, PK Cohort (Cohort B): ponsegromab low dose; Open-label, PK Cohort (Cohort B): ponsegromab medium dose
- Participants
- 455
- Sites
- 122
- Countries
- Australia, Canada, China, Czechia, Germany, Hungary, Japan, Poland, Spain, United Kingdom, United States
Trials that died the same way
- Effect of Enzymes on Dental Biofilm Accumulation in Healthy Individuals
“The study was terminated after interim data analysis” - Safety Study of the VEGA UV-A System to Treat Keratoconus
“The sponsor terminated the study prior to data analysis for financial reasons.” - GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
“The study was terminated following assessment of the lack of efficacy of the study product by the Independent Data monitoring Committee for the study.” - Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
“This study was terminated by the Sponsor.” - Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
“Study terminated as a result of interim analysis not meeting predetermined criteria.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.